Clinical Trials · NCT00586898

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
36
Start date
Jul 2001
Locations
1 site, United States
Primary endpoint
Response
View Gonadorelin compound reference